Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
113.46
+5.39 (4.99%)
At close: Oct 20, 2026, 4:00 PM EDT
114.31
+0.85 (0.75%)
Pre-market: Oct 21, 2026, 4:49 AM EDT
Kymera Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $151 | Buy | Maintains | $151 | +33.09% | Oct 15, 2026 |
| Citi | Citi | Buy Maintains $150 | Buy | Maintains | $150 | +32.21% | Oct 15, 2026 |
| Raymond James | Raymond James | Buy Initiates $140 | Buy | Initiates | $140 | +23.39% | Oct 8, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $140 | Buy | Reiterates | $140 | +23.39% | Sep 28, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 | Buy | Maintains | $140 | +23.39% | Sep 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $132 → $152 | Buy | Maintains | $132 → $152 | +33.97% | Sep 22, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $123 → $144 | Buy | Reiterates | $123 → $144 | +26.92% | Sep 14, 2026 |
| Wolfe Research | Wolfe Research | Buy Upgrades $180 | Buy | Upgrades | $180 | +58.65% | Sep 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.